Erector Spina Plane Block for Multilevel Major Spinal Surgery
Effect of Ultrasound-guided Bilateral Erector Spina Plan Block for Postoperative Analgesia in Patients Undergoing Multilevel Posterior Spinal Instrumentation.
1 other identifier
interventional
42
1 country
1
Brief Summary
Erector spinae plane (ESP) block is an interfacial plane block with visceral and somatic analgesic activity at paraspinal muscles. This study aims to examine the postoperative analgesic efficacy of ESP block in patients undergoing posterior spinal instrumentation
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable pain
Started Sep 2021
Typical duration for not_applicable pain
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2021
CompletedFirst Submitted
Initial submission to the registry
August 1, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 7, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
August 7, 2023
CompletedFirst Posted
Study publicly available on registry
August 9, 2023
CompletedOctober 10, 2023
October 1, 2023
1.9 years
August 1, 2023
October 6, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
opioid consumption
The amount of morphine consumed in milligrams in the first 24 hours was determined with a patient-controlled analgesia pump.
up to 24 hour
Study Arms (2)
Control group
SHAM COMPARATORNo block was performed
Erector spinae plane block
ACTIVE COMPARATORErector spinae plane block was performed, morphine was administered with patient-controlled analgesia (PCA) and all patients were followed in the ward.
Interventions
Erector spinae plane block was performed
Eligibility Criteria
You may qualify if:
- ASA I-III patients
- Agreed to participate in the study
You may not qualify if:
- Patients with infection at the injection site
- Coagulopathy Allergy to amide-type local anesthetics
- History of peripheral neuropathy
- Hepatic and/or renal failure
- Refusing the procedure
- Patients with heart disease
- Patients who have previously undergone surgery from the same area
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kahramanmaras Sutcu Imam University Hospital
Kahramanmaraş, 46100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Gökce Gişi
Kahramanmaras Sutcu Imam Universty
- STUDY DIRECTOR
Gözen Öksüz
Kahramanmaras Sutcu Imam Universty
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
August 1, 2023
First Posted
August 9, 2023
Study Start
September 1, 2021
Primary Completion
August 7, 2023
Study Completion
August 7, 2023
Last Updated
October 10, 2023
Record last verified: 2023-10
Data Sharing
- IPD Sharing
- Will not share